Abbreviations: ADA Americans with Disabilities Act; BMD bone mineral density; BMI body
mass index; CBAVD congenital bilateral absence of the vas deferens; CF cystic fibrosis; CFF …

The use of ursodeoxycholic acid (UDCA) in the treatment of liver maladies originates in
ancient Chinese folk medicine. Indeed, for centuries, the Chinese drugyutan'a powder …

The hydrophilic bile salt ursodeoxycholic acid (UDCA) is a potent inhibitor of apoptosis. In
this paper, we further characterize the mechanism by which UDCA inhibits apoptosis …

OBJECTIVES: To assess the tolerability and efficacy of high-dose (25–30 mg/kg per day)
ursodeoxycholic acid (UDCA) in patients with primary sclerosing cholangitis (PSC) …

BACKGROUND/AIMS: To describe the prevalence of liver disease in a cohort of 241 cystic
fibrosis (CF) patients. METHODS: 241 CF patients were followed-up every 3 months with …

Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile
acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic …

Liver disease is increasingly recognized as a major cause of morbidity in cystic fibrosis (CF).
Preliminary data suggest that ursodeoxycholic acid (UDCA) may be beneficial for treatment …

We prospectively screened for liver disease patients with cystic fibrosis who were more than
3 years of age and who were followed at the cystic fibrosis center of the University of Milan …

The efficacy of 2 years of treatment with ursodeoxycholic acid (UDCA) in cystic fibrosis (CF)-
associated liver disease was evaluated by liver biopsies and liver function tests in 10 …

Background/Aims: Intrahepatic cholestasis of pregnancy is characterized by pruritus and
increased levels of serum bile acids, and is often associated with premature delivery, fetal …